Teladoc stock slides despite business growth, Medtronic CEO talks innovation

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Teladoc’s stock slides despite business growth

Teladoc Health on Tuesday reported solid third quarter earnings showing $660 million in revenue for 8% year-over-year growth and improvement across business lines including BetterHelp and its closely watched chronic care segment.

Get unlimited access to award-winning journalism and exclusive events.

Instead of adding quality metrics, harness fewer high-quality ones to improve outcomes and reduce provider burden

Ensuring excellent quality and outcomes is the essential goal of medical care. To achieve it, a multitude of quality metrics have been added to clinicians’

May 2, 2024

#JPM24 reflections: No politics, no Miami and where the money is in biotech right now

I’m back online after a post-JP Morgan decompression, and I wanted to quickly gather a few thoughts about last week, the state of the industry,

January 18, 2024

WHO’s top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology

Jeremy Farrar, now the World Health Organization’s chief scientist, was working in Vietnam 20 years ago when the H5N1 virus started to spread across Asia

May 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.